{
    "nct_id": "NCT03429907",
    "official_title": "An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer: A Randomized Pilot Study",
    "inclusion_criteria": "1. Women with stage I-III breast cancer who are followed by the Department of Breast Medical Oncology and are recommended for neoadjuvant chemotherapy, any regimen. If chemotherapy is received in an outside facility, patients are eligible if they are scheduled to return to MD Anderson after completion of chemotherapy.\n2. Patients = or > 18 years old\n3. Patients who speak English\n4. Patients who are willing and able to review, understand, and provide written consent\n5. Patients who agree to comply with all study procedures\n6. Patients who have access to a mobile phone, tablet, or personal computer, that supports the Headspace application\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patients with a documented diagnosis of a formal thought disorder (e.g., schizophrenia)\n2. Patients who are currently or have been in the past three months actively engaged in meditation-related exercises for at least one hour a week\n3. Patients who are currently receiving psychotherapy\n4. Patients with pre-existing diagnosis of an inflammatory autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, or multiple sclerosis\n5. Patients who are currently taking adrenergic receptor antagonist (e.g., propranolol) or corticosteroids (e.g., dexamethasone, methylprednisolone)",
    "miscellaneous_criteria": ""
}